News 23 Nov 2023 biped.ai secures CHF 1.2 million for US expansion and European growth Lausanne-based start-up biped.ai, known for its revolutionary technology aiding the visually impaired, has successfully raised CHF 1.2 million.
News 12 Feb 2024 Transmutex receives CHF 20 million for its breakthrough nuclear energy technology Geneva-based Transmutex has raised over CHF 20 million to accelerate the development of its innovative nuclear energy system.
News 29 Set 2023 Top Stories from Western Switzerland (July-September 2023) From spearheading eco-innovative solutions to pioneering breakthroughs in solar technology, cancer research, sustainable shipping, and the realms...
Actualités 21 Nov 2023 Technologies quantiques en Suisse occidentale En tirant parti des promesses des technologies quantiques émergentes, la Suisse occidentale est en passe de devenir une région charnière dans ce ...
News 24 Mag 2023 Latest research shows 20% of European biotechs now headquartered in Switzerland Press release New research conducted by IQVIA and recently published in the 2023 Swiss Biotech Report shows that 20% of European biotech companies are now head...
News 06 Mar 2024 Aktiia secures CHF 27 million to combat global hypertension crisis Aktiia, a pioneering Neuchâtel-based start-up specializing in cuffless blood pressure monitoring, has announced a significant financial milestone...
News 29 Feb 2024 Top Stories from Western Switzerland (February 2024) From significant strides in semiconductor innovation and breakthroughs in medical research to strategic advancements in fintech and medtech secto...
Headquarters 15 Giu 2023 Open Your HQ Are you a biopharmaceutical company seeking to access the European market? Switzerland could be the perfect location for your commercial headquar...
Actualités 12 Feb 2024 Transmutex reçoit CHF 20 millions pour sa technologie révolutionnaire d’énergie nucléaire La société genevoise Transmutex a levé plus de CHF 20 millions pour accélérer le développement de son système innovant d’énergie nucléaire.
Aktuell 27 Ott 2023 Obwaldner Kantonalbank weiht Ideenschmiede QUBO 17 ein Die Obwaldner Kantonalbank hat den Neubau QUBO 17 in Sarnen offiziell eingeweiht. Im obersten Stock befindet sich ein Innovationslabor der Bank. ...
News 10 Mag 2023 Novostia to launch first-in-human trials for innovative artificial heart valve Novostia, a clinical-stage company focused on developing breakthrough artificial heart valves, recently announced the successful completion of it...
Spotlight 15 Giu 2023 Access to Ecosystem Switzerland is a global leader in biotech, medtech and pharma. Find out what makes the Swiss life science industry unique and how your life scien...
News 24 Apr 2023 Astrocast joins the XGain initiative to bridge the digital divide between urban and rural areas Vaud-based scale-up Astrocast, a leading global Satellite IoT network operator, has announced its participation in the European Union-funded XGai...
Actualités 22 Ago 2023 Plongée au cœur du programme « LeadiNNg to Scale-Up » d’Innovaud et de l’IMD Innovaud et IMD unissent une fois de plus leurs forces pour lancer la troisième édition du programme « LeadiNNg to Scale-Up », destiné à transfor...
News 30 Gen 2024 Top Stories from Western Switzerland (January 2024) From groundbreaking advancements in agrifood and robotics to strategic economic reforms and pioneering research in space and medicine, discover W...
Actualités 02 Giu 2023 UNE ÉTUDE RÉCENTE MONTRE QUE 20 % DES SOCIÉTÉS DE BIOTECHNOLOGIE EUROPÉENNES ONT DÉSORMAIS LEUR SIÈGE EN SUISSE Press release Une nouvelle étude menée par IQVIA et récemment publiée dans le Swiss Biotech Report 2023 montre que 20 % des sociétés de biotechnologie eur...
Aktuell 02 Giu 2023 Neuste Forschung zeigt, dass 20% der europäischen Biotechs ihren Hauptsitz in der Schweiz haben Press release Neue Untersuchungen von IQVIA, die kürzlich im Swiss Biotech Report 2023 veröffentlicht wurden, zeigen, dass mittlerweile 20% der europäischen Bi...
Novità 02 Giu 2023 Le ultime ricerche indicano che il 20% delle aziende biotecnologiche europee ha attualmente sede in Svizzera Press release Una nuova ricerca condotta da IQVIA e pubblicata recentemente nello Swiss Biotech Report 2023 mostra che il 20% delle aziende biotecnologiche eur...